221 related articles for article (PubMed ID: 28099264)
1. Post-treatment 18F-FDG-PET/CT versus contrast-enhanced CT in patients with oropharyngeal squamous cell carcinoma: comparative effectiveness study.
Taghipour M; Mena E; Kruse MJ; Sheikhbahaei S; Subramaniam RM
Nucl Med Commun; 2017 Mar; 38(3):250-258. PubMed ID: 28099264
[TBL] [Abstract][Full Text] [Related]
2. The value of follow-up FDG-PET/CT in the management and prognosis of patients with HPV-positive oropharyngeal squamous cell carcinoma.
Taghipour M; Marcus C; Califano J; Fakhry C; Subramaniam RM
J Med Imaging Radiat Oncol; 2015 Dec; 59(6):681-6. PubMed ID: 26768092
[TBL] [Abstract][Full Text] [Related]
3. PET-CT vs contrast-enhanced CT: what is the role for each after chemoradiation for advanced oropharyngeal cancer?
Chen AY; Vilaseca I; Hudgins PA; Schuster D; Halkar R
Head Neck; 2006 Jun; 28(6):487-95. PubMed ID: 16619274
[TBL] [Abstract][Full Text] [Related]
4. Association of Fludeoxyglucose F 18-Labeled Positron Emission Tomography and Computed Tomography With the Detection of Oropharyngeal Cancer Recurrence.
Sivarajah S; Isaac A; Cooper T; Zhang H; Puttagunta L; Abele J; Biron V; Harris J; Seikaly H; O' Connell DA
JAMA Otolaryngol Head Neck Surg; 2018 Nov; 144(11):1037-1043. PubMed ID: 30242338
[TBL] [Abstract][Full Text] [Related]
5. Is there an additive value of 18 F-FDG PET-CT to CT/MRI for detecting nodal metastasis in oropharyngeal squamous cell carcinoma patients with palpably negative neck?
Sohn B; Koh YW; Kang WJ; Lee JH; Shin NY; Kim J
Acta Radiol; 2016 Nov; 57(11):1352-1359. PubMed ID: 26013025
[TBL] [Abstract][Full Text] [Related]
6. Preoperative
Cho JK; Ow TJ; Lee AY; Smith RV; Schlecht NF; Schiff BA; Tassler AB; Lin J; Moadel RM; Valdivia A; Abraham T; Gulko E; Neimark M; Ustun B; Bello JA; Shifteh K
Otolaryngol Head Neck Surg; 2017 Sep; 157(3):439-447. PubMed ID: 28608737
[TBL] [Abstract][Full Text] [Related]
7. The combination of preoperative PET/CT and sentinel lymph node biopsy in the surgical management of early-stage cervical cancer.
Papadia A; Gasparri ML; Genoud S; Bernd K; Mueller MD
J Cancer Res Clin Oncol; 2017 Nov; 143(11):2275-2281. PubMed ID: 28669052
[TBL] [Abstract][Full Text] [Related]
8. Positron emission tomography/computed tomography after primary transoral robotic surgery for oropharyngeal squamous cell carcinoma.
Hobelmann K; Luginbuhl A; Bar-Ad V; Keane W; Curry J; Cognetti D
Laryngoscope; 2017 Sep; 127(9):2050-2056. PubMed ID: 28272799
[TBL] [Abstract][Full Text] [Related]
9. Accuracy of (18) FDG PET-CT for treatment evaluation 3 months after completion of chemoradiotherapy for head and neck squamous cell carcinoma: 2-year minimum follow-up.
Sagardoy T; Fernandez P; Ghafouri A; Digue L; Haaser T; de Clermont-Galleran H; Castetbon V; de Monès E
Head Neck; 2016 Apr; 38 Suppl 1():E1271-6. PubMed ID: 26315809
[TBL] [Abstract][Full Text] [Related]
10. Earlier and more specific detection of persistent neck disease with diffusion-weighted MRI versus subsequent PET/CT after definitive chemoradiation for oropharyngeal squamous cell carcinoma.
Yu Y; Mabray M; Silveira W; Shen PY; Ryan WR; Uzelac A; Yom SS
Head Neck; 2017 Mar; 39(3):432-438. PubMed ID: 27726241
[TBL] [Abstract][Full Text] [Related]
11. Fluorodeoxyglucose-positron emission tomography/computed tomography performs better than contrast-enhanced computed tomography for metastasis evaluation in the initial staging of pancreatic adenocarcinoma.
Santhosh S; Mittal BR; Bhasin DK; Rana SS; Gupta R; Das A; Nada R
Ann Nucl Med; 2017 Oct; 31(8):575-581. PubMed ID: 28689356
[TBL] [Abstract][Full Text] [Related]
12. Three-Dimensional Image Fusion of
Yu Y; Zhang WB; Liu XJ; Guo CB; Yu GY; Peng X
J Oral Maxillofac Surg; 2017 Jun; 75(6):1301.e1-1301.e15. PubMed ID: 28320612
[TBL] [Abstract][Full Text] [Related]
13. Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography After Concurrent Chemoradiotherapy in Locally Advanced Head-and-Neck Squamous Cell Cancer: The ECLYPS Study.
Van den Wyngaert T; Helsen N; Carp L; Hakim S; Martens MJ; Hutsebaut I; Debruyne PR; Maes ALM; van Dinther J; Van Laer CG; Hoekstra OS; De Bree R; Meersschout SAE; Lenssen O; Vermorken JB; Van den Weyngaert D; Stroobants S;
J Clin Oncol; 2017 Oct; 35(30):3458-3464. PubMed ID: 28854069
[TBL] [Abstract][Full Text] [Related]
14. Performance of 18F-FDG PET/contrast-enhanced CT in the staging of squamous cell carcinoma of the oral cavity and oropharynx.
Krabbe CA; Balink H; Roodenburg JL; Dol J; de Visscher JG
Int J Oral Maxillofac Surg; 2011 Nov; 40(11):1263-70. PubMed ID: 21824748
[TBL] [Abstract][Full Text] [Related]
15. Planned neck dissection after chemoradiotherapy in advanced oropharyngeal squamous cell cancer: the role of US, MRI and FDG-PET/TC scans to assess residual neck disease.
Pellini R; Manciocco V; Turri-Zanoni M; Vidiri A; Sanguineti G; Marucci L; Sciuto R; Covello R; Sperduti I; Kayal R; Anelli V; Pichi B; Mercante G; Spriano G
J Craniomaxillofac Surg; 2014 Dec; 42(8):1834-9. PubMed ID: 25150165
[TBL] [Abstract][Full Text] [Related]
16. [18F]Fluorodeoxyglucose (FDG)-Positron Emission Tomography (PET)/Computed Tomography (CT) in Suspected Recurrent Breast Cancer: A Prospective Comparative Study of Dual-Time-Point FDG-PET/CT, Contrast-Enhanced CT, and Bone Scintigraphy.
Hildebrandt MG; Gerke O; Baun C; Falch K; Hansen JA; Farahani ZA; Petersen H; Larsen LB; Duvnjak S; Buskevica I; Bektas S; Søe K; Jylling AM; Ewertz M; Alavi A; Høilund-Carlsen PF
J Clin Oncol; 2016 Jun; 34(16):1889-97. PubMed ID: 27001573
[TBL] [Abstract][Full Text] [Related]
17. [Role of 18F-FDG PET/CT in comparison with CECT for whole-body assessment of patients with esophageal cancer.].
Altini C; Niccoli Asabella A; Lavelli V; Bianco G; Ungaro A; Pisani A; Merenda N; Ferrari C; Rubini G
Recenti Prog Med; 2019 Mar; 110(3):144-150. PubMed ID: 30968855
[TBL] [Abstract][Full Text] [Related]
18. [Value of positron emission tomography with 18-fluorodeoxyglucose (FDG-PET) in early detection of residual tumor in oro-pharyngeal-laryngeal carcinoma].
Haenggeli CA; Dulguerov P; Slosman D; Becker M; Bang P; Allal A; Guyot JP; Lehmann W
Schweiz Med Wochenschr Suppl; 2000; 116():8S-11S. PubMed ID: 10780061
[TBL] [Abstract][Full Text] [Related]
19. Integrated 18F-FDG PET/CT for the initial evaluation of cervical node level of patients with papillary thyroid carcinoma: comparison with ultrasound and contrast-enhanced CT.
Jeong HS; Baek CH; Son YI; Choi JY; Kim HJ; Ko YH; Chung JH; Baek HJ
Clin Endocrinol (Oxf); 2006 Sep; 65(3):402-7. PubMed ID: 16918964
[TBL] [Abstract][Full Text] [Related]
20. Radiographic Imaging Does Not Reliably Predict Macroscopic Extranodal Extension in Human Papilloma Virus-Associated Oropharyngeal Cancer.
Patel MR; Hudgins PA; Beitler JJ; Magliocca KR; Griffith CC; Liu Y; Bougnon K; El-Deiry M; Saba NF; Aiken AH
ORL J Otorhinolaryngol Relat Spec; 2018; 80(2):85-95. PubMed ID: 29969771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
